Last reviewed · How we verify
Etacizin (ethacizine)
Etacizin (generic name: ethacizine) is a ethacizine drug. It is currently in unknown development for Supraventricular arrhythmia, Ventricular arrhythmia.
Etacizin works by blocking potassium channels in the heart, which helps to regulate abnormal heart rhythms.
Etacizin is a small molecule class Ic antiarrhythmic agent. It is used to treat severe and/or refractory ventricular and supraventricular arrhythmias, particularly those accompanied by organic heart disease, and refractory tachycardia associated with Wolff–Parkinson–White syndrome.
At a glance
| Generic name | ethacizine |
|---|---|
| Drug class | ethacizine |
| Therapeutic area | Cardiovascular |
| Phase | unknown |
Mechanism of action
Think of the heart as a muscle that needs to beat in a regular rhythm. Potassium channels help control how fast the heart muscle contracts and relaxes. By blocking these channels, etacizin helps to slow down the heart rate and restore a normal rhythm.
Approved indications
- Supraventricular arrhythmia
- Ventricular arrhythmia
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Etacizin CI brief — competitive landscape report
- Etacizin updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Etacizin
What is Etacizin?
How does Etacizin work?
What is Etacizin used for?
What is the generic name of Etacizin?
What drug class is Etacizin in?
What development phase is Etacizin in?
Related
- Drug class: All ethacizine drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Cardiovascular
- Indication: Drugs for Supraventricular arrhythmia
- Indication: Drugs for Ventricular arrhythmia
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing